Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Jones

Showing results (181-190 of 945) with videos related to

Pageof 95
Sort By:
Diagnostic Microbiology and Infectious Disease|June 23, 1998
Combinations of orally administered beta-lactams to maximize spectrum and activity against drug-resistant respiratory tract pathogens: I. Synergy studies of amoxicillin and cefixime with Streptococcus pneumoniaeR N Jones, D M Johnson
The Pediatric Infectious Disease Journal|October 1, 1987
Cefixime: spectrum of antibacterial activity against 16,016 clinical isolatesA L Barry, R N Jones
Antimicrobial Agents and Chemotherapy|March 1, 1985
Antimicrobial activity of HR810 against 419 strict anaerobic bacteriaR N Jones, E H Gerlach
European Journal of Clinical Microbiology|February 1, 1987
Unpredictable influence of human serum on antimicrobial activity of erythromycin and three oxime ether macrolidesR N Jones, A L Barry
Journal of Clinical Microbiology|September 1, 1987
Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk testsR N Jones, A L Barry
Archives of Pathology & Laboratory Medicine|July 1, 1985
Antibiotic susceptibility testing accuracy. Review of the College of American Pathologists Microbiology Survey, 1972-1983R N Jones, D C Edson
Diagnostic Microbiology and Infectious Disease|January 1, 1994
North American (United States and Canada) comparative susceptibility of two fluoroquinolones: ofloxacin and ciprofloxacin. A 53-medical-center sample of spectra of activity. North American Ofloxacin Study GroupR N Jones, D J Hoban
Diagnostic Microbiology and Infectious Disease|January 1, 1994
Postantibiotic effect of DU-6859a and levofloxacin as compared with ofloxacinA K Houston, R N Jones
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 20, 2003
Antimicrobial activity against strains of Escherichia coli and Klebsiella spp. with resistance phenotypes consistent with an extended-spectrum beta-lactamase in EuropeR N Jones, M A Pfaller,
European Journal of Clinical Microbiology|October 1, 1987
Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892R N Jones, A L Barry
Pageof 95

Showing results (181-190 of 945) with videos related to

Sort By:
Pageof 95
Diagnostic Microbiology and Infectious Disease|June 23, 1998
Combinations of orally administered beta-lactams to maximize spectrum and activity against drug-resistant respiratory tract pathogens: I. Synergy studies of amoxicillin and cefixime with Streptococcus pneumoniaeR N Jones, D M Johnson
The Pediatric Infectious Disease Journal|October 1, 1987
Cefixime: spectrum of antibacterial activity against 16,016 clinical isolatesA L Barry, R N Jones
Antimicrobial Agents and Chemotherapy|March 1, 1985
Antimicrobial activity of HR810 against 419 strict anaerobic bacteriaR N Jones, E H Gerlach
European Journal of Clinical Microbiology|February 1, 1987
Unpredictable influence of human serum on antimicrobial activity of erythromycin and three oxime ether macrolidesR N Jones, A L Barry
Journal of Clinical Microbiology|September 1, 1987
Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk testsR N Jones, A L Barry
Archives of Pathology & Laboratory Medicine|July 1, 1985
Antibiotic susceptibility testing accuracy. Review of the College of American Pathologists Microbiology Survey, 1972-1983R N Jones, D C Edson
Diagnostic Microbiology and Infectious Disease|January 1, 1994
North American (United States and Canada) comparative susceptibility of two fluoroquinolones: ofloxacin and ciprofloxacin. A 53-medical-center sample of spectra of activity. North American Ofloxacin Study GroupR N Jones, D J Hoban
Diagnostic Microbiology and Infectious Disease|January 1, 1994
Postantibiotic effect of DU-6859a and levofloxacin as compared with ofloxacinA K Houston, R N Jones
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 20, 2003
Antimicrobial activity against strains of Escherichia coli and Klebsiella spp. with resistance phenotypes consistent with an extended-spectrum beta-lactamase in EuropeR N Jones, M A Pfaller,
European Journal of Clinical Microbiology|October 1, 1987
Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892R N Jones, A L Barry
Pageof 95